[Icariin reduces S-nitrosogultathione induced endothelial cell apoptosis through modulating AKT/P53 pathway]
- PMID: 27545131
- DOI: 10.3760/cma.j.issn.0253-3758.2016.08.013
[Icariin reduces S-nitrosogultathione induced endothelial cell apoptosis through modulating AKT/P53 pathway]
Abstract
Objective: To observe the effects of icariin on S-nitrosogultathione(GSNO) induced endothelial cell apoptosis, and to explore the relative mechanisms.
Methods: EA.hy926 cell line was provided by Zhejiang University and cells were divided into blank control group, GSNO group (1 mmol/L GSNO), icariin (ICA) intervention group (GSNO+ different concentrations (high, medium and low: 10, 1 and 0.1 μmol/L ICA) and 1 μmol/L LY294002 pretreatment groups (AKT protease pathway inhibitor on top of ICA groups) by cluster random sample method. After 48 hours. EA.hy 926 cell survival was detected by thiazolyl blue tetrazolium bromicle (MTT) method. Lactate dehydrogenase (LDH) activity, malonaldehyde (MDA) content, reactive oxygen species (ROS) level, mitochondrial membrane potential were also measured. The protein expression of protein kinase B(AKT)/phosphorylation protein kinase B(p-AKT), people tumor-suppressor protein (protein 53, P53), cytochrome C (CYC), endothelial nitric oxide synthetase (eNOS)/phosphorylation endothelial nitric oxide synthetase (p-eNOS), procaspase-3/caspase-3 was detected by Western blot.
Results: (1) The cell survival rate was significantly lower in GSNO group than in the blank control group (P< 0.01), which was significantly higher in the high, medium and low concentration ICA groups than in the GSNO group (all P< 0.01). (2) The LDH activity was significantly higher in the GSNO group than in the blank control group ((142.65±5.56) U/L vs. (50.01±3.42) U/L, P< 0.05), which was significantly reduced by high, medium and low concentration ICA ((98.02±3.52), (105.29±6.89) and (117.16±4.27) U/L vs. (142.65±5.56) U/L, all P< 0.05) in a dose-dependent manner. (3) The MDA content was significantly higher in GSNO group than in the blank control group ((11.14±0.37) nmol/mg vs. (5.21±0.18) nmol/mg, P< 0.05), which could be reduced by pretreatment with high, medium and low concentration ICA ((6.60±0.41), (6.83±0.21) and (8.29±0.07) nmol/mg vs. (11.14 ±0.37) nmol/mg, all P< 0.05). (4) The ROS content was significantly higher in GSNO group than in the blank control group ((173.15±11.12)% (relative ratio to the blank control group), P< 0.05), which could be significantly reduced by pretreatment with high, medium and low concentration ICA ((122.56±8.09)%, (134.52±9.09)%, and(149.89±9.16)% (the ratio of the above are compared with the blank control group), P< 0.05). (5) The mitochondrial membrane potential was significantly higher in the GSNO group (0.84 ± 0.04) than in the blank control group (0.12 ±0.12), which could be significantly reduced by pretreatment with high, medium and low concentration ICA ((0.57±0.08), (0.63±0.02), (0.66±0.04) vs. (0.84±0.04), all P<0.05). (6) The expression of AKT/p-AKT was significantly lower in GSNO group than in the blank control group (P< 0.05), which could be significantly upregulated by pretreatment with high, medium and low concentration ICA in a concentration-dependent manner, above effects could be blocked by LY294002 (all P<0.05). (7) The expression of P53 was significantly higher in GSNO group than in the blank control group (P< 0.05), which could be significantly down regulated by pretreatment with high, medium and low concentration ICA in a concentration-dependent manner, above effects could be blocked by LY294002(all P<0.05). (8) The expression of CYC and caspase-3 was significantly reduced in the mitochondria and increased in cytoplasm post GSNO treatment compared to blank control group, which could be reversed by pretreatment with high, medium and low concentration ICA(all P<0.05). (9) The expression of eNOS/p-eNOS was similar between GSNO and the blank control group, while it was significantly upregulated by pretreatment with high, medium and low concentration ICA and this effect could be blocked by LY294002(all P<0.05).
Conclusion: Icariin could reduce GSNO induced endothelial cell apoptosis through activating AKT pathway and downregulating P53 activity.
Similar articles
-
Overexpression of microRNA-138 alleviates human coronary artery endothelial cell injury and inflammatory response by inhibiting the PI3K/Akt/eNOS pathway.J Cell Mol Med. 2017 Aug;21(8):1482-1491. doi: 10.1111/jcmm.13074. Epub 2017 Mar 31. J Cell Mol Med. 2017. PMID: 28371277 Free PMC article.
-
Phosphocreatine protects endothelial cells from oxidized low-density lipoprotein-induced apoptosis by modulating the PI3K/Akt/eNOS pathway.Apoptosis. 2015 Dec;20(12):1563-76. doi: 10.1007/s10495-015-1175-4. Apoptosis. 2015. PMID: 26404526
-
Icariin delays homocysteine-induced endothelial cellular senescence involving activation of the PI3K/AKT-eNOS signaling pathway.Pharm Biol. 2013 Apr;51(4):433-40. doi: 10.3109/13880209.2012.738332. Epub 2013 Jan 22. Pharm Biol. 2013. PMID: 23336586
-
[Effect of Tongxinluo on Apoptosis of Rat Cardiac Microvascular Endothelial Cells].Zhongguo Zhong Xi Yi Jie He Za Zhi. 2016 Jun;36(6):709-17. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2016. PMID: 27491231 Chinese.
-
Potential enhancement of post-stroke angiogenic response by targeting the oligomeric aggregation of p53 protein.Front Cell Neurosci. 2023 Jul 18;17:1193362. doi: 10.3389/fncel.2023.1193362. eCollection 2023. Front Cell Neurosci. 2023. PMID: 37534043 Free PMC article. Review.
Cited by
-
Icariin reduces human colon carcinoma cell growth and metastasis by enhancing p53 activities.Braz J Med Biol Res. 2018 Aug 6;51(10):e7151. doi: 10.1590/1414-431X20187151. Braz J Med Biol Res. 2018. PMID: 30088538 Free PMC article.
-
Icariin, an Anti-atherosclerotic Drug from Chinese Medicinal Herb Horny Goat Weed.Front Pharmacol. 2017 Oct 12;8:734. doi: 10.3389/fphar.2017.00734. eCollection 2017. Front Pharmacol. 2017. PMID: 29075193 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous